Table 3.
Literature review: clinical outcome of MECA.
| Reference | N | Nodal metastasis | Recurrence (all) | Local recurrence | Distant metastasis | DOD |
|---|---|---|---|---|---|---|
| Nagao 1998 (14) | 10 | NA | 2/9 (22%) | NA | 3/9 (33%) | 4/9 (44%) |
| Savera 2000 (4) | 25 | 2/16 (13%) | 10/17 (59%) | 10/17 (59%) | 6/16 (38%) | 5/17 (29%) |
| Yang 2010 (6) | 7 | 1/7 (14%) | 0/5 (0%) | 0/5 (0%) | 0/5 (0%) | 0/5 (0%) |
| Kane 2010 (7) | 51 | 7/17 (41%) | 21/51 (41%) | 18/51 (35%) | 3/51 (11%) | 0/51 (0%) |
| Wang 2015 (8) | 29 | 7/25 (28%) | 11/27 (47%) | NA | 7/25 (27%) | 2/23 (9%) |
| Kong 2015 (3) | 48 | 4/40 (8%) | NA | 9/44 (20%) | 12/44 (27%) | NA |
| Skalova 2015 (9) | 25 | 5/21 (24%) | 12/21 (57%) | 11/21 (52%) | 7/21 (33%) | 8/21 (38%) |
| Total (from all previous studies) | 195 | 26/126 (21%) | 56/130 (43%) | 48/138 (35%) | 38/171 (22%) | 19/126 (15%) |
| Current study | 21 | 0/21 (0%) | 14/16 (87%) | 10/16 (63%) | 5/16 (31%) | 2/16 (13%) |